We describe the development of the HIV epidemic in Karonga District, Malawi over 22 years using data from population surveys and community samples. These data are used to estimate the trend in HIV prevalence, incidence and need for antiretroviral treatment (ART) using a simple mathematical model. HIV prevalence rose quickly in the late 1980s and early 1990s, stabilizing at around 12% in the mid-1990s. Estimated annual HIV incidence rose quickly, peaking in the early 1990s at 2.2% among males and 3.1% among females, and then levelled off at 1.3% among males and 1.1% among females by the late 1990s. Assuming a 2-year eligibility period, both our model and the UNAIDS models predicted 2.1% of adults were in need of ART in 2005. This prediction ...
Objective: National estimates of HIV trends in generalized epidemics rely on HIV prevalence data fro...
Introduction: HIV planning requires granular estimates for the number of people living with HIV (PLH...
Introduction: The antiretroviral therapy (ART) programme supported by Médecins Sans Frontières in th...
We describe the development of the HIV epidemic in Karonga District, Malawi over 22 years using data...
We describe the development of the HIV epidemic in Karonga District, Malawi over 22 years using data...
BACKGROUND: Approximately 1 million people are infected with HIV in Malawi, where AIDS is the leadin...
Background: Most data on HIV prevalence in Malawi come from antenatal clinic (ANC) surveillance a...
BACKGROUND: In 1992 Liomba et al used HIV-AIDS prevalence data from 1980 to 1990 and projected the a...
In 1992 Liomba et al used HIV-AIDS prevalence data from 1980 to 1990 and projected the adult HIV pre...
Background: Surveillance in the era of antiretroviral therapy (ART) requires estimates of HIV pr...
HIV prevalence has recently begun to decline in Zimbabwe, a result of both high levels of AIDS morta...
OBJECTIVE: To investigate the prevalence and sociodemographic risk factors for HIV infection, during...
HIV testing and antiretroviral therapy (ART) has scaled up tremendously in Malawi in the last 5 year...
INTRODUCTION: HIV planning requires granular estimates for the number of people living with HIV (PLH...
The HIV/AIDS epidemic is one of the world’s leading causes of death, particularly in sub-Saharan Afr...
Objective: National estimates of HIV trends in generalized epidemics rely on HIV prevalence data fro...
Introduction: HIV planning requires granular estimates for the number of people living with HIV (PLH...
Introduction: The antiretroviral therapy (ART) programme supported by Médecins Sans Frontières in th...
We describe the development of the HIV epidemic in Karonga District, Malawi over 22 years using data...
We describe the development of the HIV epidemic in Karonga District, Malawi over 22 years using data...
BACKGROUND: Approximately 1 million people are infected with HIV in Malawi, where AIDS is the leadin...
Background: Most data on HIV prevalence in Malawi come from antenatal clinic (ANC) surveillance a...
BACKGROUND: In 1992 Liomba et al used HIV-AIDS prevalence data from 1980 to 1990 and projected the a...
In 1992 Liomba et al used HIV-AIDS prevalence data from 1980 to 1990 and projected the adult HIV pre...
Background: Surveillance in the era of antiretroviral therapy (ART) requires estimates of HIV pr...
HIV prevalence has recently begun to decline in Zimbabwe, a result of both high levels of AIDS morta...
OBJECTIVE: To investigate the prevalence and sociodemographic risk factors for HIV infection, during...
HIV testing and antiretroviral therapy (ART) has scaled up tremendously in Malawi in the last 5 year...
INTRODUCTION: HIV planning requires granular estimates for the number of people living with HIV (PLH...
The HIV/AIDS epidemic is one of the world’s leading causes of death, particularly in sub-Saharan Afr...
Objective: National estimates of HIV trends in generalized epidemics rely on HIV prevalence data fro...
Introduction: HIV planning requires granular estimates for the number of people living with HIV (PLH...
Introduction: The antiretroviral therapy (ART) programme supported by Médecins Sans Frontières in th...